— Know what they know.
Not Investment Advice

MAZE NASDAQ

Maze Therapeutics, Inc.
1W: -2.6% 1M: -2.8% 3M: -41.8% YTD: -35.2% 1Y: +154.7%
$25.78
+0.03 (+0.12%)
 
Weekly Expected Move ±6.1%
$22 $24 $26 $27 $29
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 40 · $1.4B mcap · 16M float · 5.42% daily turnover · Short 56% of daily vol
Last Earnings 2026-05-13
EPS
$-0.45
▲ Beat +22.0%
Revenue
$11M
Est (actual pending)
EPS Beat Streak: 4 quarters
Next Earnings 2026-08-18
EPS Estimate
$-0.72
Range: $-0.77 - $-0.64
Revenue Estimate
$3M
6 analysts

Estimate vs Actual

Earnings Surprise History

4/11
EPS Beats
0/11
Revenue Beats
36%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-22 quarter 2026-09-30 $-0.74 $-0.76 ▼ 0.02 $333,333 $333,333
2026-05-22 annual 2028-12-31 $-3.59 $-3.63 ▼ 0.04 $10,674,571 $10,674,571
2026-05-22 annual 2026-12-31 $-2.70 $-2.75 ▼ 0.05 $20,000,000 $20,000,000
2026-05-22 annual 2029-12-31 $-3.81 $-3.87 ▼ 0.05 $50,979,167 $50,979,167
2026-05-22 annual 2027-12-31 $-3.17 $-3.22 ▼ 0.05 $13,900,000 $13,900,000
2026-05-22 quarter 2026-06-30 $-0.70 $-0.72 ▼ 0.02 $2,555,556 $2,555,556
2026-05-22 quarter 2026-12-31 $-0.77 $-0.79 ▼ 0.02 $333,333 $333,333
2026-05-22 annual 2030-12-31 $-2.54 $-2.59 ▼ 0.05 $214,548,625 $212,652,125
2026-05-20 quarter 2026-09-30 $-0.74 $-0.74 $333,333 $333,333
2026-05-20 quarter 2026-12-31 $-0.76 $-0.77 ▼ 0.01 $333,333 $333,333
2026-05-20 quarter 2026-06-30 $-0.71 $-0.70 ▲ 0.01 $2,555,556 $2,555,556
2026-05-20 annual 2027-12-31 $-3.18 $-3.17 ▲ 0.01 $13,900,000 $13,900,000
2026-05-20 annual 2028-12-31 $-3.56 $-3.59 ▼ 0.03 $10,674,571 $10,674,571
2026-05-20 annual 2026-12-31 $-2.69 $-2.70 ▼ 0.01 $20,000,000 $20,000,000
2026-05-18 quarter 2026-06-30 $-0.70 $-0.71 ▼ 0.01 $3,111,111 $2,555,556
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms